United States Biotechnology & Medical Research

Sunesis Pharmaceuticals Inc (SNSS)

Track

Ticker: SNSS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Proposed sale 27 Feb 2024
Value US$1,501,600.55 | Price 53.00 | Shares 75,841
Sale 27 Feb 2024
Value US$1,076,229.80 | Price 57.93 | Shares 21,586 (-26.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-27 2024-02-27 PrS Proposed sale
3.2
Chevallard Daniel R.

Officer

Officer
75,841
53.00
US$1,501,601 		75,841 53.00 US$1,501,601
2024-02-27 2024-02-27 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
21,586 -26.8%
57.93
US$1,076,230 		21,586 -26.8% 57.93 US$1,076,230
2023-12-04 2023-12-01 B Purchase
Rothera Mark

President and CEO

Executive Director
28,426 -38.3%
262.54
US$2,855,204 		28,426 -38.3% 262.54 US$2,855,204
2023-12-04 2023-11-30 B Purchase
Rothera Mark

President and CEO

Executive Director
52,094 +inf%
0.49
US$25,734 		52,094 +inf% 0.49 US$25,734
2023-11-28 2023-11-28 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,720 -3.6%
0.50
US$1,860 		3,720 -3.6% 0.50 US$1,860
2023-08-29 2023-08-28 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,512 -3.5%
1.45
US$5,092 		3,512 -3.5% 1.45 US$5,092
2023-05-26 2023-05-26 PrS Proposed sale
3.2
Chevallard Daniel R.

Officer

Officer
3,635
1.42
US$5,160 		3,635 1.42 US$5,160
2023-05-26 2023-05-25 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,635 -3.8%
1.42
US$5,160 		3,635 -3.8% 1.42 US$5,160
2023-02-28 2023-02-27 S Sale
Rojkjaer Lisa

Chief Medical Officer

Officer
2,156 -4.3%
1.68
US$3,625 		2,156 -4.3% 1.68 US$3,625
2023-02-28 2023-02-27 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,599 -3.9%
1.68
US$6,051 		3,599 -3.9% 1.68 US$6,051
2022-11-29 2022-11-28 S Sale
Rojkjaer Lisa

Chief Medical Officer

Officer
2,116 -4.4%
2.72
US$5,754 		2,116 -4.4% 2.72 US$5,754
2022-11-29 2022-11-28 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,532 -4.0%
2.72
US$9,606 		3,532 -4.0% 2.72 US$9,606
2022-08-29 2022-08-26 S Sale
Rojkjaer Lisa

Chief Medical Officer

Officer
2,190 -4.7%
4.01
US$8,786 		2,190 -4.7% 4.01 US$8,786
2022-08-29 2022-08-26 S Sale
ROYSTON IVOR

CEO & President

Executive Director
13,379 -2.1%
4.01
US$53,656 		13,379 -2.1% 4.01 US$53,656
2022-08-29 2022-08-26 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,655 -4.2%
4.02
US$14,679 		3,655 -4.2% 4.02 US$14,679
2022-05-27 2022-05-26 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,596 -4.3%
1.90
US$6,836 		3,596 -4.3% 1.90 US$6,836
2022-05-27 2022-05-26 S Sale
Rojkjaer Lisa

Chief Medical Officer

Officer
2,154 -4.9%
1.90
US$4,095 		2,154 -4.9% 1.90 US$4,095
2022-05-27 2022-05-26 S Sale
ROYSTON IVOR

CEO & President

Executive Director
13,162 -2.1%
1.90
US$25,022 		13,162 -2.1% 1.90 US$25,022
2022-03-01 2022-02-28 S Sale
Rojkjaer Lisa

Chief Medical Officer

Officer
2,395 -5.6%
2.78
US$6,657 		2,395 -5.6% 2.78 US$6,657
2022-03-01 2022-02-28 S Sale
ROYSTON IVOR

CEO & President

Executive Director
14,635 -2.4%
2.78
US$40,678 		14,635 -2.4% 2.78 US$40,678
2022-03-01 2022-02-28 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,998 -5.0%
2.78
US$11,112 		3,998 -5.0% 2.78 US$11,112
2021-11-29 2021-11-29 S Sale
Rojkjaer Lisa

Chief Medical Officer

Officer
2,591 -6.3%
4.82
US$12,486 		2,591 -6.3% 4.82 US$12,486
2021-11-29 2021-11-29 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
4,325 -5.6%
4.82
US$20,843 		4,325 -5.6% 4.82 US$20,843
2021-11-29 2021-11-29 S Sale
ROYSTON IVOR

CEO & President

Executive Director
15,833 -2.7%
4.82
US$76,301 		15,833 -2.7% 4.82 US$76,301
2021-11-29 2021-11-26 S Sale
Rojkjaer Lisa

Chief Medical Officer

Officer
1,950 -4.5%
4.80
US$9,361 		1,950 -4.5% 4.80 US$9,361
2021-11-29 2021-11-26 S Sale
3.2
Chevallard Daniel R.

CFO and COO

Officer
3,254 -4.0%
4.80
US$15,621 		3,254 -4.0% 4.80 US$15,621
2021-11-29 2021-11-26 S Sale
ROYSTON IVOR

CEO & President

Executive Director
11,914 -2.0%
4.80
US$57,194 		11,914 -2.0% 4.80 US$57,194
2021-11-15 2021-11-15 B Purchase
ROYSTON IVOR

CEO & President

Executive Director
8,000 +1.5%
5.56
US$44,480 		8,000 +1.5% 5.56 US$44,480
2020-06-05 2020-05-29 B Purchase
Gullotta Tina

VP, Finance

Officer
6,000 +41.4%
0.33
US$1,989 		6,000 +41.4% 0.33 US$1,989
2020-04-02 2019-11-29 B Purchase
1.6
Quinn William P.

See Remarks
6,000 +4.9%
0.37
US$2,193 		6,000 +4.9% 0.37 US$2,193
2019-07-15 2019-07-15 B Purchase
Aisling Capital IV, LP
Large shareholder
2,500,000 +32.9%
0.60
US$1,500,000 		2,500,000 +32.9% 0.60 US$1,500,000
2020-04-02 2019-05-31 B Purchase
1.6
Quinn William P.

See Remarks
6,000 +5.2%
0.65
US$3,877 		6,000 +5.2% 0.65 US$3,877
2018-12-12 2018-12-10 B Purchase Quinn William P.

CFO,Sr.V.P. Finance, Corp.Dev.

Officer
40,000 +333.3%
0.47
US$18,800 		40,000 +333.3% 0.47 US$18,800
2017-11-06 2017-11-06 B Purchase MPM Oncology Impact Management GP LLC Large shareholder
16,200 +0.5%
2.77
US$44,874 		16,200 +0.5% 2.77 US$44,874
2017-11-06 2017-11-03 B Purchase MPM Oncology Impact Management GP LLC Large shareholder
40,000 +1.2%
2.89
US$115,600 		40,000 +1.2% 2.89 US$115,600
2017-11-06 2017-11-02 B Purchase MPM Oncology Impact Management GP LLC Large shareholder
25,300 +0.8%
2.59
US$65,527 		25,300 +0.8% 2.59 US$65,527
2017-10-30 2017-10-27 B Purchase Misfeldt Dayton
7,480 +32.6%
2.00
US$14,960 		7,480 +32.6% 2.00 US$14,960
2017-10-30 2017-10-27 B Purchase Misfeldt Dayton
392,520 +32.6%
2.00
US$785,040 		392,520 +32.6% 2.00 US$785,040
2016-12-12 2016-12-09 B Purchase Parker Geoffrey M. Non-Executive Director
594 +0.9%
3.90
US$2,318 		594 +0.9% 3.90 US$2,318
2016-12-12 2016-12-08 B Purchase Parker Geoffrey M. Non-Executive Director
3,146 +5.1%
3.87
US$12,159 		3,146 +5.1% 3.87 US$12,159
2016-05-27 2016-05-26 B Purchase Parker Geoffrey M. Non-Executive Director
9,500 +18.1%
0.47
US$4,455 		9,500 +18.1% 0.47 US$4,455
2016-05-26 2016-05-25 B Purchase Parker Geoffrey M. Non-Executive Director
22,505 +75.0%
0.49
US$10,933 		22,505 +75.0% 0.49 US$10,933
2016-05-26 2016-05-24 B Purchase Parker Geoffrey M. Non-Executive Director
30,000 +inf%
0.46
US$13,881 		30,000 +inf% 0.46 US$13,881
2015-12-21 2015-12-21 B Purchase Misfeldt Dayton Non-Executive Director
32,725 +31.1%
0.84
US$27,489 		32,725 +31.1% 0.84 US$27,489
2015-12-21 2015-12-21 B Purchase Misfeldt Dayton Non-Executive Director
1,717,275 +31.1%
0.84
US$1,442,511 		1,717,275 +31.1% 0.84 US$1,442,511
2015-08-26 2015-08-25 B Purchase Swisher Daniel N JR

President and CEO

Executive Director
12,216 +6.5%
1.01
US$12,338 		12,216 +6.5% 1.01 US$12,338
2015-08-26 2015-08-24 B Purchase Swisher Daniel N JR

President and CEO

Executive Director
12,784 +7.3%
1.01
US$12,912 		12,784 +7.3% 1.01 US$12,912
2015-12-21 2015-07-24 S Sale Misfeldt Dayton Non-Executive Director
3,962 -3.6%
3.64
US$14,422 		3,962 -3.6% 3.64 US$14,422
2015-12-21 2015-07-24 S Sale Misfeldt Dayton Non-Executive Director
7,925 -7.4%
3.46
US$27,420 		7,925 -7.4% 3.46 US$27,420
2015-12-21 2015-07-24 S Sale Misfeldt Dayton Non-Executive Director
207,938 -3.6%
3.46
US$719,465 		207,938 -3.6% 3.46 US$719,465
2015-12-21 2015-07-24 S Sale Misfeldt Dayton Non-Executive Director
415,877 -7.4%
3.46
US$1,438,934 		415,877 -7.4% 3.46 US$1,438,934
2015-07-28 2015-07-24 S Sale Ketchum Steven B Non-Executive Director
2,119 -2.5%
3.46
US$7,329 		2,119 -2.5% 3.46 US$7,329
2015-07-28 2015-07-24 S Sale Ketchum Steven B Non-Executive Director
4,239 -5.0%
3.46
US$14,661 		4,239 -5.0% 3.46 US$14,661
2015-07-28 2015-07-24 B Purchase Swisher Daniel N JR

President and CEO

Executive Director
25,000 +16.7%
1.02
US$25,458 		25,000 +16.7% 1.02 US$25,458
2015-07-28 2015-07-24 S Sale Swisher Daniel N JR

President and CEO

Executive Director
4,238 -2.8%
3.46
US$14,657 		4,238 -2.8% 3.46 US$14,657
2015-07-28 2015-07-24 S Sale Swisher Daniel N JR

President and CEO

Executive Director
8,477 -5.6%
3.46
US$29,318 		8,477 -5.6% 3.46 US$29,318
2015-07-28 2015-07-24 S Sale BJERKHOLT ERIC

EVP, CFO & Corp. Secretary

Officer
2,119 -2.5%
3.46
US$7,329 		2,119 -2.5% 3.46 US$7,329
2015-07-28 2015-07-24 S Sale BJERKHOLT ERIC

EVP, CFO & Corp. Secretary

Officer
4,239 -5.0%
3.46
US$14,661 		4,239 -5.0% 3.46 US$14,661
2015-07-28 2015-07-24 S Sale BAY CITY CAPITAL LLC Large shareholder
3,962 -0.1%
3.46
US$13,709 		3,962 -0.1% 3.46 US$13,709
2015-07-28 2015-07-24 S Sale BAY CITY CAPITAL LLC Large shareholder
7,925 -0.1%
3.46
US$27,420 		7,925 -0.1% 3.46 US$27,420
2015-07-28 2015-07-24 S Sale BAY CITY CAPITAL LLC Large shareholder
207,938 -3.6%
3.46
US$719,465 		207,938 -3.6% 3.46 US$719,465
2015-07-28 2015-07-24 S Sale BAY CITY CAPITAL LLC Large shareholder
415,877 -7.3%
3.46
US$1,438,934 		415,877 -7.3% 3.46 US$1,438,934
2014-08-29 2014-08-29 S Sale BASKETT FOREST Large shareholder
11,600 -0.2%
7.51
US$87,070 		11,600 -0.2% 7.51 US$87,070
2014-08-29 2014-08-29 S Sale KERINS PATRICK J Large shareholder
11,600 -0.2%
7.51
US$87,070 		11,600 -0.2% 7.51 US$87,070
2014-08-29 2014-08-29 S Sale DRANT RYAN D Large shareholder
11,600 -0.2%
7.51
US$87,070 		11,600 -0.2% 7.51 US$87,070
2014-08-29 2014-08-29 S Sale BARRIS PETER J Large shareholder
11,600 -0.2%
7.51
US$87,070 		11,600 -0.2% 7.51 US$87,070
2014-08-29 2014-08-29 S Sale
2.4
SANDELL SCOTT D
Large shareholder
11,600 -0.2%
7.51
US$87,070 		11,600 -0.2% 7.51 US$87,070
2014-08-29 2014-08-29 S Sale KOLLURI KRISHNA KITTU Large shareholder
11,600 -0.2%
7.51
US$87,070 		11,600 -0.2% 7.51 US$87,070
2014-08-29 2014-08-29 S Sale BARRETT M JAMES Large shareholder
11,600 -0.2%
7.51
US$87,070 		11,600 -0.2% 7.51 US$87,070
2014-08-29 2014-08-29 S Sale Growth Equity Opportunities Fund, LLC Large shareholder
11,600 -0.2%
7.51
US$87,070 		11,600 -0.2% 7.51 US$87,070
2014-08-29 2014-08-28 S Sale BASKETT FOREST Large shareholder
146,800 -3.0%
7.87
US$1,154,846 		146,800 -3.0% 7.87 US$1,154,846
2014-08-29 2014-08-28 S Sale KERINS PATRICK J Large shareholder
146,800 -3.0%
7.87
US$1,154,846 		146,800 -3.0% 7.87 US$1,154,846
2014-08-29 2014-08-28 S Sale DRANT RYAN D Large shareholder
146,800 -3.0%
7.87
US$1,154,846 		146,800 -3.0% 7.87 US$1,154,846
2014-08-29 2014-08-28 S Sale Misfeldt Dayton Non-Executive Director Large shareholder
3,740 -4.2%
7.89
US$29,490 		3,740 -4.2% 7.89 US$29,490
2014-08-29 2014-08-28 S Sale Misfeldt Dayton Non-Executive Director Large shareholder
196,260 -4.2%
7.89
US$1,547,530 		196,260 -4.2% 7.89 US$1,547,530
Explore more

More insider trading research around Sunesis Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America